Neuroleptic side effects

acute extrapyramidal syndromes and tardive dyskinesia.

Daniel Casey, George Keepers

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

The neuroleptic-induced motor system side effects of acute extrapyramidal syndromes (EPS) and tardive dyskinesia (TD) are the major limitations of these drugs. Effective strategies for managing these problems are based on the clinical presentations, pathophysiological processes, and a complex interaction of patient and treatment variables. New concepts about the causes and long-term outcome of acute EPS and TD are emerging to challenge some of the commonly held views about these syndromes. The primary method of preventing undue side effects is to use the lowest effective dose of both neuroleptic and anti-EPS drugs. The pressing need is for novel compounds which treat schizophrenia and are free of the undesirable motor system effects (a nonneuroleptic neuroleptic).

Original languageEnglish (US)
Pages (from-to)74-93
Number of pages20
JournalPsychopharmacology series
Volume5
StatePublished - 1988
Externally publishedYes

Fingerprint

Antipsychotic Agents
Pharmaceutical Preparations
Schizophrenia
Tardive Dyskinesia
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Neuroleptic side effects : acute extrapyramidal syndromes and tardive dyskinesia. / Casey, Daniel; Keepers, George.

In: Psychopharmacology series, Vol. 5, 1988, p. 74-93.

Research output: Contribution to journalArticle

@article{fb4cab3a977846bab836cb5d2eae153d,
title = "Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia.",
abstract = "The neuroleptic-induced motor system side effects of acute extrapyramidal syndromes (EPS) and tardive dyskinesia (TD) are the major limitations of these drugs. Effective strategies for managing these problems are based on the clinical presentations, pathophysiological processes, and a complex interaction of patient and treatment variables. New concepts about the causes and long-term outcome of acute EPS and TD are emerging to challenge some of the commonly held views about these syndromes. The primary method of preventing undue side effects is to use the lowest effective dose of both neuroleptic and anti-EPS drugs. The pressing need is for novel compounds which treat schizophrenia and are free of the undesirable motor system effects (a nonneuroleptic neuroleptic).",
author = "Daniel Casey and George Keepers",
year = "1988",
language = "English (US)",
volume = "5",
pages = "74--93",
journal = "Psychopharmacology series",
issn = "0931-6795",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Neuroleptic side effects

T2 - acute extrapyramidal syndromes and tardive dyskinesia.

AU - Casey, Daniel

AU - Keepers, George

PY - 1988

Y1 - 1988

N2 - The neuroleptic-induced motor system side effects of acute extrapyramidal syndromes (EPS) and tardive dyskinesia (TD) are the major limitations of these drugs. Effective strategies for managing these problems are based on the clinical presentations, pathophysiological processes, and a complex interaction of patient and treatment variables. New concepts about the causes and long-term outcome of acute EPS and TD are emerging to challenge some of the commonly held views about these syndromes. The primary method of preventing undue side effects is to use the lowest effective dose of both neuroleptic and anti-EPS drugs. The pressing need is for novel compounds which treat schizophrenia and are free of the undesirable motor system effects (a nonneuroleptic neuroleptic).

AB - The neuroleptic-induced motor system side effects of acute extrapyramidal syndromes (EPS) and tardive dyskinesia (TD) are the major limitations of these drugs. Effective strategies for managing these problems are based on the clinical presentations, pathophysiological processes, and a complex interaction of patient and treatment variables. New concepts about the causes and long-term outcome of acute EPS and TD are emerging to challenge some of the commonly held views about these syndromes. The primary method of preventing undue side effects is to use the lowest effective dose of both neuroleptic and anti-EPS drugs. The pressing need is for novel compounds which treat schizophrenia and are free of the undesirable motor system effects (a nonneuroleptic neuroleptic).

UR - http://www.scopus.com/inward/record.url?scp=0023747883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023747883&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 74

EP - 93

JO - Psychopharmacology series

JF - Psychopharmacology series

SN - 0931-6795

ER -